Anand Mehra, Director at Aclaris Therapeutics, Inc. (ACRS), bought 1,333,332 shares at $2.25 ($3.0M) on 2024-11-19, disclosed to the SEC on 2024-11-20.
Open-market purchase of $3.0M ACRS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.25 | 666,666 | $1.5M | 50.0% |
| 2 | $2.25 | 666,666 | $1.5M | 50.0% |
| Total | $2.25 avg | 1,333,332 | $3.0M | 100% |
| Filing → |
| ONCE | SELL | 2017-06-22 | $410K | — | Filing → |
| ONCE | SELL | 2017-03-06 | $2.0M | — | Filing → |
| ONCE | SELL | 2017-03-01 | $11.0M | — | Filing → |